In 1981 a murine monoclonal antibody OC 125 was developed by the hybridization of mouse cells that had been immunized with epithelial ovarian carcinoma cell lines1. CA 125, the corresponding soluble oncofetal antigen, became widely used as a tumour marker2.
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CASE HISTORY
A 32-year-old Vietnamese woman gave a 2-week history of abdominal distension, weight loss, generalised malaise and an unproductive cough. She had been resident in the UK since 1980 and had no history of recent travel abroad. On admission her temperature was 36.4°C but subsequently it was noted to be spiking. She was cachectic with signs of ascites. Her cardiovascular and respiratory systems were unremarkable.
Routine investigations revealed a normochromic normocytic anaemia, mild lymphopenia and a slightly raised plasma viscosity. Blood cultures and sputum samples showed no growth. Urea and electrolytes were normal but alanine aminotransferase, alkaline phosphatase, and gamma-glutamyltransferase were all above normal at 120, 821, and 93 IU/L, respectively; C-reactive protein was also raised at 19 mg/L. Four days after admission a repeat chest radiograph showed newly formed bilateral pleural effusions, and abdominal ultrasonography confirmed the presence of ascitic fluid with a heterogeneous liver, polycystic kidneys, and a 4.5 x 4 cm left adnexal mass. Mantoux tests and ,B human chorionic gonadotropin were negative and paracentesis showed a mature lymphocytic exudate with no specific growth on microscopy. The level of CA 125 in serum was 417 KU/L (normal <30), increasing our suspicions of ovarian malignancy. Over subsequent days she deteriorated despite the use of various antibiotics. Computed tomography revealed a large heterogeneous mass with solid and cystic components in the left side of the pelvis.
At laparotomy 3 L of straw-coloured ascitic fluid was drained and the omental cake proved to be adherent to the anterior abdominal wall. The uterus itself appeared normal but was fixed and both tubes and ovaries were enlarged with 'tumour' stuck to the side walls of the pelvis. The peritoneum was thickened with numerous miliary seedlings involving the small and large bowel and the dome of the liver and diaphragm. An omental biopsy and a left salpingooophorectomy was performed and the histology results were pessimistically awaited.
Biopsy specimens revealed multiple caseating epitheloid cell granulomata, and Ziehl-Neelsen staining for acid-alkali fast bacilli was positive. No malignant cells were evident. Therapy with isoniazid, rifampicin and pyrazinamide was started, with striking improvement in her symptoms. Nine months later, after completion of treatment, she had regained 10 kg in weight and her CA 125 levels were normal. COMMENT Raised levels of the oncofetal antigen have been found in patients with pancreatitis, renal failure and alcoholic hepatitis, in various gynaecological conditions such as endometriosis, salpingitis and uterine fibroma2, and in ascites due to tuberculous peritonitis3, liver cirrhosis and hepatocellular carcinoma4. Thus, CA 125 is a poor diagnostic screening tool for ovarian carcinoma when used on its own (its sensitivity and specificity are much better in postmenopausal than in premenopausal women5). Bergmann et al.4 proposed that CA 125 was indeed a nonspecific marker of ascites or peritoneal inflammation. For patients with ovarian carcinoma, CA 125 levels were noted to be raised in 89% of patients with ascitic fluid but in just over 20% of those without. The CA 125 was raised in nearly all of their patients with ascites, the origin being ovarian carcinoma, hepatocellular carcinoma or liver cirrhosis. Penna and co-workers6 have reported a case similar to ours. The lesson is that, however strong the pointers to ovarian carcinoma, diagnosis should await the results of histological examination.
